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ABSTRACT: 
Microbial rhodopsins, a photoactive membrane protein family, serve as fundamental tools for 
optogenetics, an innovative technology to control biological activities with light. Microbial 
rhodopsins are widely distributed in nature and have a wide variety of biological functions. 
Regardless of many different types of microbial rhodopsins known, only few of them have so far 
been used in optogenetics for controlling neural activity to understand neural networks. The efforts 
of our group have been aimed at identifying and characterizing novel rhodopsins from nature and 
also at engineering novel variant rhodopsins by rational design. Based on the molecular and 
functional characteristics of those novel rhodopsins, we have proposed new rhodopsin-based 
optogenetics tools to control not only neural activities but also ”non-neural” activities. In this 
perspective, we introduce the achievements and summarize future challenges in creating 
optogenetics tools using rhodopsins. The implementation of optogenetics deep inside an in-vivo 
brain is the well-known challenge for existing rhodopsins. As a perspective to address this 
challenge, we introduce innovative optical illumination techniques using wavefront shaping that 
can reinforce low light sensitivity of the rhodopsins and realize deep-brain optogenetics. The 
applications of our optogenetics tools could be extended to manipulate non-neural biological 
activities such as gene expression, apoptosis, energy production and muscle contraction. We also 
discuss the potentially unlimited biotechnological applications of microbial rhodopsins in the 
future such as in photovoltaic devices and in drug delivery systems. We believe that advances in 
the field will greatly expand the potential uses of microbial rhodopsins as optical tools.  
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Biological responses are composed of various cellular activities in which complicated chemical 
processes of biological molecules (e.g. proteins, nucleotides, peptides and ions) are precisely 
regulated. To understand such biological responses, researchers have analyzed cellular activities 
and chemical processes of molecules using biochemical and biophysical methods. In the 21st 
century, as an innovative way to break through that limitation, an optical technique termed 
“optogenetics” has emerged. Optogenetics allows us to have control over the biological activities 
of living cells and organisms by genetically expressing photoactive proteins.1-4 As classical 
methods to actively control biological activities, chemical administration, physical stimulation and 
genetic modification have been utilized. However, those methods are partially invasive even to 
non-targeted cells. In contrast, the light stimulation used in optogenetics is non-invasive and offers 
high spatial- and time- resolutions. Therefore, optogenetics has become a focus of interest as a 
promising technique to non-invasively control biological activities.5 As optogenetics tools, various 
photoactive proteins, such as microbial rhodopsins, animal opsins and their chimeric proteins (i.e. 
optoXRs), and flavoproteins, have been used (Table 1).6-16 Actually, microbial rhodopsins have 
been used for optical control of neural activities by ion transportation5, 17 whereas animal opsins 
and optoXRs can optically control G protein signaling cascade and neural activities.18, 19 Moreover, 
flavoproteins have been used for optical regulation of gene expression, cAMP production and 




Table 1. Optogenetic application of photoactive proteins.  
 
 
Microbial rhodopsins are seven-transmembrane photoactive proteins containing vitamin A 
aldehyde retinal as a chromophore (Fig. 1A).21, 22 Exceptionally, enzyme rhodopsins, which exhibit 
guanylate cyclase and cyclic nucleotide phosphodiesterase activities, have one extra helix 
upstream of the seven-transmembrane helices.23, 24 The retinal covalently binds to the apoprotein 
opsin via a protonated Schiff base linkage with a conserved Lys residue located in the last helix. 
The trans-cis photoisomerization of the retinal triggers sequential conformational changes of the 
opsin during which the biological function is induced. After the sequential reactions, microbial 
rhodopsins return to the initial state by heat absorption ( in Figure 1B), which is called as 
photocycle.21 The cyclic reaction allows microbial rhodopsins to repeatedly exhibit their functions 
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every light stimulation, which is advantageous to optogenetics in contrast to vertebrate visual 
opsins (i.e. vertebrate rhodopsin and cone visual pigments) in which the retinal is dissociated after 
photoreaction and the additional retinal is required to regenerate the pigments.21, 25 Recent progress 
in genomics and bioinformatics revealed that microbial rhodopsins are widely distributed in all 
three biological domains, archaea, bacteria and eukarya, and have diverse functions such as 
outward proton pumps, inward chloride pumps, outward sodium pumps, inward proton pumps, 
cation channels, anion channels, phototaxis sensors, transcriptional regulators and enzymes (Fig. 
1B).21, 22 Rhodopsins have also been discovered in viruses.26 The work by Nagel et al. molecularly 
and functionally characterized a light-gated cation channel with demonstration of light-induced 
depolarization of vertebrate cells (i.e. Xenopus oocytes and HEK293 cells), and then the authors 
named this new protein Channelrhodopsin-2.3 As a first demonstration of optogenetics controlling 
neural activities, Deisseroth and coworkers utilized a channelrhodopsin with which genetically-
modified neurons were successfully depolarized.6 Around the same time, other groups controlled 
neural activities with Channelrhodopsin-2,27-30 provided by the authors of ref. 3 27-29 or synthesized 
according to ref. 3.30 Since then, neuroscience researchers have started to regulate the neural 
activities of specific neurons using microbial rhodopsin-based optogenetics tools to investigate 
effects on biological activities, such as memory, learning, motion, sleep and awakening.5, 17, 31 In 
addition, a few of microbial rhodopsins, such as Archaerhodopsin-3 (AR3) and proteorhodopsin 
(PR), have been utilized as the genetically encoded voltage indicators since they exhibit voltage-
dependent fluorescence changes in the cells (Table 1).32, 33 Through numerous optogenetic 
analyses combined with optical observations, the causality between biological functions and 
chemical processes in living cells has been clearly elucidated in the neuroscience field. However, 
regardless of many different types of microbial rhodopsins known, only few of them have so far 
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been used as optogenetics tools in the neuroscience field, which limits the expansion of application 
using rhodopsin-based optogenetics tools (e.g. deep tissue illumination, non-neural optogenetics, 
and tuning and enhancing photochemistry) in the life science field. In this perspective, we 
introduce the achievements and summarize future challenges to produce rhodopsin-based 
optogenetics tools.  
 
Figure 1. Introduction of diverse microbial rhodopsins.  
(A) Crystal structure of bacteriorhodopsin (BR) from the archaeon Halobacterium salinarum  
(PDB code; 1C3W) as the most-studied microbial rhodopsin.34 EC and IC indicate extracellular 
and intracellular sides, respectively. The retinal covalently binds to the apoprotein opsin and its 
isomerization from the all-trans to the 13-cis form is triggered by light (hv). (B) Phylogenetic tree 
of representative microbial rhodopsin amino acid sequences. Rhodopsins from bacteria, eukarya 
and archaea are indicated by ellipses filled with blue, green and red, respectively. Rhodopsins used 
as optogenetics tools in our research are indicated by bold characters.: Archaerhodopsin-3 (AR3), 
anabaena sensory rhodopsin (ASR), Guillardia theta anion channelrhodopsin-1 and -2 (GtACR1 
and GtACR2, respectively), Rubricoccus marinus xenorhodopsin (RmXeR), Rubrobacter 
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xylanophilus rhodopsin (RxR), Synechocystis halorhodopsin (SyHR), and Thermophilic 
rhodopsin (TR). All the sequences used to construct the phylogenetic tree are listed in 
Supplementary Table S1. Up arrow and down arrow represent the direction of ion transportation, 
i.e. outward direction from IC to EC and inward direction from EC to IC, respectively. 
 
Optical control of neural activities 
After the first demonstration of optogenetics controlling neural activities using Chlamydomonas 
reinhardtii channelrhodopsins-2 (CrChR2),6, 27-29 various natural and engineered 
channelrhodopsin variants with characteristic properties (e.g., fast and slow channel closing, and 
blue- and red-shifted spectral sensitivities) have been discovered from nature and produced by 
mutational analysis as neural activation tools.35-39 As a neural silencing tool, an inward chloride 
pump, NpHR, was firstly demonstrated to induce hyperpolarization responses in light-dependent 
manner.7, 8 After that, several ion-pumping rhodopsins and their variants (e.g. an archaeal outward 
proton pumping rhodopsin, AR3 and an outward sodium pump, KR2) were demonstrated as neural 
silencing tools.9, 10, 40 We also have actively explored and characterized novel microbial rhodopsins 
from nature,22 and we have succeeded in modifying their functions and properties as novel variant 
molecules.41 By understanding and exploiting the functions and characteristics of rhodopsins, we 
have been proposing new optogenetics tools (Fig. 2). We term this strategy composed of 
‘Exploration’, ‘Modification’ and ‘Application’ as a bottom-up approach. In 2012, we identified 
an outward proton pumping rhodopsin named Thermophilic rhodopsin (TR) from an extremely 
thermophilic bacterium Thermus thermophilus,42 which has an extremely-high thermal stability 
among rhodopsins. Therefore, we expected that the high stability of TR would allow it to be 
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functionally expressed without denaturation and misfolding in animal cells. To confirm this, we 
attempted to use TR as a neural silencing tool in living C. elegans (Fig. 2, upper and lower 
panels).12 TR was well-expressed in neurons as we expected and could indeed cause locomotion 
paralysis by silencing neural activities. A similar result has been obtained with AR3.43 Next, we 
used ion channeling rhodopsins as neural silencing tools. In general, upon illumination, ion 
pumping rhodopsins transport only one ion during each photocycle whereas ion channeling 
rhodopsins transport numerous ions, resulting in highly efficient hyperpolarization responses in 
neurons. In addition, proton pumping rhodopsins such as AR3 move a proton across the cell 
membrane and their long-term activation may decrease the extracellular pH, which would induce 
undesired secondary effects in neurons, suggesting that other substrate ions (i.e. Cl- and Na+) are 
favorable for neural silencing. In 2015, Spudich and coworkers discovered two light-gated anion 
channelrhodopsins (GtACR1 and GtACR2) from the cryptophyte algae Guillardia theta and 
demonstrated that GtACRs selectively conduct monovalent anions such as Cl- and generate a larger 
photocurrent (approximately 1000-fold) than AR3 in mammalian cells.11 Therefore, GtACRs are 
expected to be much more efficient silencing tools without pH changes as a secondary effect.44, 45 
We used GtACR1 and GtACR2 as neural silencing tools in neurons of C. elegans and mice.46, 47 
GtACR1 and GtACR2 could cause locomotion paralysis at around 1 μW/cm2 light intensity, which 
is three orders of magnitude smaller than the light intensity required by AR3 (1 mW/cm2).46 In 
mouse neurons, GtACR2 also showed efficient and temporally-stable neural silencing effects.47 In 
addition, GtACRs are less harmful to worms under long-term illumination.46 Those studies 
demonstrated that GtACR1 and GtACR2 work as hypersensitive and harmless neural silencing 
tools in most neural regions  (Fig. 2, upper and lower panels). Note that, for specific regions such 
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as presynaptic terminal in the hippocampus where the intracellular Cl- concentration is lower than 
the extracellular one,48  GtACRs would not be the efficient silencing tool. 
 
Figure 2. Optical control of neural activities. 
Schematic of bottom-up approach to produce optogenetics tools to control neural activity. Bottom-
up approach consists of three parts; ’Exploration’, ‘Modification’ and ‘Application’. Among the 
rhodopsins prepared by the ‘Exploration’ and ‘Modification’ steps in this bottom-up approach, 
appropriate rhodopsins for neural control are chosen in the ‘Application’ step. EC and IC indicate 
extracellular and intracellular sides, respectively. 
 
By exploiting our ability to produce novel variants of rhodopsins with characteristic 
functions and properties by rationally introducing mutations, we have been using those mutant 
rhodopsins at optogenetics tools. As a first example, we introduce here a blue-shifted AR3 
mutant.49 Archaeal proton pumping rhodopsins such as AR3 generally absorb green and yellow 
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light (550 - 570 nm). We succeeded in producing a ~50 nm blue-shifted AR3 mutant by 
introducing several mutations around the retinal chromophore while maintaining its robust proton 
pumping activity (Fig. 2, middle panel). Therefore, this AR3 mutant should be useful as a blue 
light sensitive neural silencing tool. Using the same strategy, we also produced a blue-shifted 
mutant of a chimera of cation channelrhodopsins, C1C2 (Fig. 2, middle panel).50 In fact, we could 
depolarize mouse neurons expressing that mutant with 445 nm blue light (Fig. 2, upper panel). 
Summarizing the above studies, many achievements of our research group on the 
exploration and modification of novel rhodopsins has expanded the potential of rhodopsins to 
precisely control neural activities for optogenetics (Table 1). However, when one wants to use 
these novel rhodopsins in in-vivo brain of rodent, an optical fiber needs to be inserted into the 
region of interest. The reason is that the light sensitivity of the rhodopsins is not sufficient enough 
currently and the use of the fiber that can efficiently deliver lights reinforces such the low 
sensitivity. The insertion of the optical fiber is very invasive to the brain and therefore the 
implementation of optogenetics analysis without the fiber in the intact brain has been highly 
desired. In the following subsection, as a future perspective for deep-brain optogenetics without 
an optical fiber, we will briefly shift our focus from microbial rhodopsins to state-of-the-art optical 
illumination techniques. 
 
Implementation of optogenetics deep inside the brain 
Mice have deep complex brains (~5 mm) and have become one of the best-suited models to 
optogenetically study high-level brain functions such as memory, learning, anger and sexual 
behavior. However, heterogeneous structures in the brain scatters visible light severely and such 
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the light scattering makes the implementation of optogenetics in the deep brain impossible (Figs. 
3A and 3C). In this section, we briefly explain difficulties, current strategies, and potential 
breakthrough towards deep-brain optogenetics based on two different illumination targets, “neural 
population” and “a single neuron”. 
 
Figure 3. Optogenetics in the deep mouse brain implemented by complex wavefront shaping. 
(A) Non-shaped light is scattered severely within the mouse brain, preventing light from 
penetrating deep inside the brain. (B) Wavefront-shaped light representing a minimum 
eigenchannel can minimize reflected lights and can be efficiently delivered into the deep brain. 
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The wavefront Φmin generating the minimum eigenchannel can be acquired from the single value 
decomposition of the reflection matrix for the brain. (C) Non-shaped light through a focusing lens 
makes no clear focus deep inside the brain due to the multiple scattering. (D) By modulating the 
wavefront Φus of ultrasound-labelled light, the wavefront-shaped light counteracts the effect of the 
multiple scattering and creates a tight focused spot deep inside the brain. The optimal wavefront 
Φus can be obtained by creating an ultrasound focus by a transducer and detecting the wavefront 
of ultrasound-labelled light. 
 
i) Manipulating neural population deep inside brain 
A correlation between specific neural population and behavioral response has been investigated 
by using diffused lights from the tip of an inserted optical fiber. In contrast, interrogating the entire 
mouse brain non-invasively without an optical fiber, a long-awaited dream for neuroscience 
researchers, has been still difficult to achieve. This is because the severe light scattering prevents 
incident light from being delivered efficiently into deep brain regions (Fig. 3A). Ion-channeling 
rhodopsins such as CrChR2 and GtACRs have been chosen as high light-sensitive molecular tools 
in the mouse brain since they generate a large photocurrent. However, even with the channeling 
rhodopsins, the deepest region at which the activity of the neural population can be controlled 
without the fiber is up to around 1 mm from the brain surface. As molecular approaches to extend 
that depth limitation, ion-channeling rhodopsins have been extensively engineered such that they 
exhibit a larger photocurrent or absorb red light maximally.38, 39, 51 The most effective approach so 
far would be the injection of up-conversion nanoparticles (UCNP) within the region of interest 
since the UCNP allows near-infrared (NIR) light illumination that has a much lower scattering 
coefficient in the brain compared with visible light.52, 53 However, all those current approaches are 
still not sufficient to non-invasively activate neural population within the whole mouse brain. 
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Here, as an emerging optical solution to tackle this challenge, we introduce a novel coherent 
illumination technique called ‘complex wavefront shaping’ (Fig. 3).54-57 This class of technique 
has been one of the hottest topics in the photonics community since it can physically overcome the 
‘light scattering’ that occurs within a disordered medium such as a biological tissue and it could 
potentially be a breakthrough for optical imaging and optogenetics deep inside biological tissues.55, 
56 
The wavefront shaping technique modulates the input wavefront of coherent light with a 
spatial light modulator (SLM) in a way to counteract multiple light scattering within a disordered 
medium. To determine the optimal input wavefront for overcoming the scattering, the input-output 
relationships of the medium, termed the transmission matrix (TM) or reflection matrix (RM), must 
be characterized by sequentially measuring output light fields for large number of independent 
input light fields (typically ~1000). One fascinating benefit for measuring the TM is its 
eigenvectors, termed eigenchannels. Since the eigenvalue of the TM represents the transmittance 
of the medium, an eigenchannel with a maximum eigenvalue will give the maximum attainable 
transmittance. The physical interpretation for this is that the optimal eigenchannel can cause strong 
constructive interference of scattered light at the rear side of the medium. Note that, when one 
wants to apply this method in in-vivo mouse brain where its rear side is optical inaccessible, the 
RM is used instead of the TM and its eigenchannel with a minimum eigenvalue can greatly reduce 
the reflectance and enhance the light transported into deep brain region. In the first demonstration 
using a ZnO nanoparticle layer, the eigenchannel from the TM could indeed enhance the 
transmitted light energy by a factor of around 4 compared with ‘non-shaped’ input light.54 One 
might expect that such a result should also be expected in the mouse brain, in other words, the 
eigenchannel from the RM should help scattered light go deeper in the brain. However, the truth 
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is that eigenchannel-based wavefront shaping has never been available so far in the in-vivo mouse 
brain. The reason is that, while the measurement of the matrix requires several seconds to complete 
even with a high-speed camera, the temporal scattering response of the in-vivo mouse brain varies 
temporally in a millisecond timescale due to parameters such as the blood flow and the heartbeat.58 
Thus, the eigenchannel extracted from that measured matrix would no longer be valid. 
Unfortunately, no effective solutions that can overcome this time constraint has been proposed so 
far. Therefore, perhaps, we may need to wait for the emergence of an ultra-fast camera offering 
several hundred kHz frame rates. Once this technological challenge is overcome, it should be 
possible to apply the eigenchannel-based wavefront shaping in the optogenetics of in-vivo mouse 
brain (Fig. 3B). This novel wavefront shaping can be seen as the tool that enhances scattered and 
weakened light deep inside the brain, not as the tool that can solely accomplish the whole brain 
optogenetics. Perhaps, together with the wavefront shaping, using NIR light mediated by the 
UCNP may enable optogenetics in the whole mouse brain. If we can engineer rhodopsin-
carotenoid complex that are NIR light-sensitive (see the section of ‘Focusing on chromophore’), 
such the molecule complex can be used in the place of the UCNP. 
 
ii) Targeting a single neuron deep inside brain 
As we described before, optogenetic researchers generally aim to manipulate the activities 
of neural populations by using ‘diffused light’ (Fig. 3A). Meanwhile, manipulating a single neuron 
with high-spatial resolution ‘focused light’, termed targeted optogenetics, has also drawn attention 
recently59, 60 since it may address important neuroscientific questions such as the precise definition 
of neural identity and the number of neurons required to influence animal behaviors.61 In such 
targeted optogenetics, the applicable depth in the brain is limited by the degradation of the quality 
of focused light due to the light scattering. The current strategy employed for the targeted 
 15 
optogenetics is a multi-photon excitation using NIR focused light since it can simply reduce the 
number of light scattering due to the use of the longer wavelength.62 However, this method still 
relies on non-scattered light (ballistic light) and the manipulation of a single neuron at more than 
a 1 mm depth in the brain is intrinsically difficult (Fig. 3C). 
Complex wavefront shaping is one promising technique to greatly extend this limited depth 
by effectively exploiting scattered light (non-ballistic light). To determine an optimal wavefront 
that can gather scattered light into a spot within the disordered medium, a ‘focused ultrasound spot’ 
as a guidestar needs to be placed at the target position of interest. This ultrasound spot modulates 
scattered light in frequency, in other words the scattered light passing through the ultrasound spot 
is frequency-labelled. By retrieving the wavefront of such labelled light with a camera and 
reconstructing that wavefront with the SLM, the shaped light will be refocused deep within the 
disordered medium (Fig. 3D). The ability to focus scattered light has been validated at a depth of 
2.5 mm within ex-vivo chicken tissue.55 More importantly, this guidestar-assisted wavefront 
shaping has already taken the first step in the optogenetics field, in which a single neuron has been 
successfully stimulated deep within the brain of a mouse.56 Our question here is whether we can 
adapt the wavefront shaping into an in-vivo mouse brain. Fortunately, unlike measuring the whole 
transmission matrix, the calibration process for acquiring the optimal wavefront only requires a 
single snapshot with a camera. The fastest calibration time reported so far was 3 ms,63 which is 
slightly slower than the scattering response (~1 ms) of the mouse brain. Therefore, within the next 
several years we should be able to see the implementation of guidestar-assisted wavefront shaping 
for manipulating a single neuron in the deep mouse brain. Such deep-brain optogenetics using 
wavefront shaping could be extended to rats and monkeys with larger brain volumes. 
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Optical control of non-neural activities 
Ion concentrations are involved not only in neural activities but also in non-neural activities. As 
mentioned above, microbial rhodopsins are representative molecules that can actively transport 
various kinds of ions and interact with various signal transduction molecules in a light-dependent 
manner.22 So far, rhodopsins have been utilized mainly to control “neural” activity. To overcome 
that situation and to further exploit the potential of optogenetics, we have been developing “non-
neural” optogenetics on the basis of the characteristics of novel rhodopsins. 
In 2006, we succeeded in converting the function of an archaeal outward proton pumping 
rhodopsin into a photosensor by strategically introducing mutations.64 The light illumination could 
indeed control the motility of a previously non light-sensitive null mutant of the archaeon H. 
salinarum by expressing the photosensor variant (Fig. 4A). Although this study has been carried 
out for experimentally verifying the functional conversion, it may be categorized as a first example 
of our “non-neural” optogenetics-like work in the context of successfully manipulating the 
biological activity of ‘non light-sensitive’ cells by the heterologous expression of photoactive 
proteins. Moreover, as a second example, we introduced the optical regulation of gene expression 
in bacteria. Anabaena sensory rhodopsin (ASR) was isolated in 2003 from the cyanobacterium 
Anabaena PCC7120.65 Although the biological function of ASR was unclear, some researchers 
hypothesized that ASR regulates gene expression in response to light.66-68 To experimentally 
validate that hypothesis, we introduced the ASR gene and the promoter sequence of the pigment 
protein phycocyanin with a reporter gene into E. coli cells.69 The results revealed that the light-
activated ASR inhibited the reporter gene expression. In other words, we succeeded in the optical 




Figure 4. Optical control of non-neural activities. 
(A) Optical control of the motility of archaeal cells. The engineered-photosensor variant triggers 
a signal transduction cascade and regulates the rotational direction of the flagellar motor. (B) 
Optogenetic regulation of gene/protein expression. The light-activated ASR inhibits gene 
expression in bacterial cells. (C) Optogenetic regulation of cell death. By intentionally decreasing 
the intracellular pH using the inward proton pump RmXeR, it may be possible to induce cell death. 
(D) Optogenetic ATP production. SyHR could be an optogenetic ATP production tool in living 
organisms. (E) Optogenetic regulation of Ca2+-dependent biological activities. The light-driven 
Ca2+ transporter may enable us to control numerous biological activities such as proliferation, 
secretion and muscle contraction. Upper, middle and lower panels represent the schematic images 
of the functions of individual rhodopsins, those of biological and chemical reactions induced by 
the rhodopsins in the cells, and those of the activities of the cells and organisms, respectively. EC 
and IC indicate extracellular and intracellular sides in all panels, respectively. 
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Furthermore, the ability of rhodopsins to transport various ions can also be exploited to 
regulate non-neural activities. Recently, we identified two novel ion-transporting rhodopsins. The 
first such rhodopsin is RmXeR from a marine bacterium, Rubricoccus marinus, which we 
characterized as a light-driven inward proton pump (Fig. 4C).70 It has been reported that 
intracellular acidification induces an apoptosis signal (e.g. release of cytochrome C from 
mitochondria, caspase activation and nuclear fragmentation) in mammalian cells.71 Hence, by 
intentionally decreasing the intracellular pH inside cells using the inward proton pump RmXeR, it 
may be possible to induce cell death. Therefore, RmXeR could be an optogenetic regulator of cell 
death in living organisms (Fig. 4C). The second such rhodopsin is SyHR from a cyanobacterium 
Synechocystis sp. PCC 7509.72 In the situation where transportable substrate ions have been 
believed to be limited to monovalent ions, we demonstrated that SyHR transports a divalent 
polyatomic sulfate ion (SO4
2-) (Fig. 4D), indicating the possibility that SyHR controls intracellular 
SO4
2- concentration. SO4
2- is known to be involved in a variety of activation and detoxification 
processes of many compounds (e.g. steroids, catecholamines and isoproterenol) for 
biotransformation and excretion in mammalian cells.73 Therefore, the optical control of 
intracellular sulfate ion concentration using SyHR should be useful to regulate those biological 
functions. In addition, SyHR may transport other divalent polyatomic ions such as HPO4
2- (Fig. 
4D). In living cells, the rate of ATP synthesis depends on the intracellular HPO4
2- concentration 
because the phosphoric acid of HPO4
2- is utilized for ATP synthesis.74 ATP provides energy to 
drive almost all processes in living cells. Thus, SyHR could be an optogenetic energy regulation 
tool in living organisms (Fig. 4D). On the other hand, rhodopsin-based Ca2+ transporters should 
be significantly valuable since changes in Ca2+ concentration would trigger numerous intracellular 
signaling cascades such as muscle contraction, cell proliferation, cell death (apoptosis), cell 
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differentiation, secretion of neurotransmitters and gene expression.75, 76 CrChR2 is permeable to 
Ca2+ and improved mutants with higher Ca2+ conductance has been reported,3, 37, 77 however, Ca2+ 
permeability of the mutants was still lower than those of other cations such as Na+ and K+. We are 
now aiming to characterize a native light-driven highly Ca2+-selective transporter and to produce 
an artificial one by introducing mutations in cation transport rhodopsins such as sodium pumping 
rhodopsin and cation channelrhodopsin (Fig. 4E). 
 
Focusing on the chromophore  
As described above, the classic strategy to alter the functions and properties of rhodopsins is to 
genetically engineer the protein moiety, opsin.41 In this section, we describe our efforts focusing 
on the chromophore as an alternative strategy. The spectral sensitivity of rhodopsins significantly 
depends on the structure of the chromophore in the opsin.78 Indeed, it is known that retinal analogs 
cause spectral shifts in many rhodopsins.79-81 We also succeeded in functional conversion by the 
replacement of the retinal chromophore. Specifically, we produced a light-gated proton channeling 
rhodopsin with a leaky outward proton pump activity from an outward proton pumping rhodopsin 
by replacing the natural chromophore (A1- and A2-retinal) of wild-type AR3 with a retinal 
analogue, C(14)-vinylene A2-retinal (Fig. 5A, lower panel).81 The proton channel induces 
hyperpolarization or depolarization depending on the electrochemical gradients across the cell 
membrane, whereas the leaky proton pump activity induces hyperpolarization. Therefore, the 
produced proton channel with the leaky outward proton pump could be utilized as 
hyperpolarization and depolarization tool in neurons (Fig. 5A, upper panel). However, the passive 
and active photocurrents of the proton channel were as small as the current of typical proton pumps 
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Thus, the increase of photocurrents is required for its application as optogenetics tools. Thus, using 
a retinal analog as the chromophore would provide the ability to modulate the absorption 
maximum and functions of rhodopsins as optogenetics tools (Fig. 5A).  
 
Figure 5. Modulating the spectral sensitivity and functions of microbial rhodopsins by retinal 
analogs and secondary chromophore attachment. 
(A) Modification of spectral sensitivities by replacement with synthetic retinal analogs. The retinal 
analogs modulate the absorption maximum of rhodopsins according to their structural 
characteristics. The retinal analog, C(14)-vinylene A2-retinal, converts a proton pump into a 
proton channel with a leaky proton pump activity. (B) Modification of spectral sensitivities by 
attaching a carotenoid as a second chromophore. The attachment of an appropriate carotenoid may 
allow us to produce NIR light-sensitive rhodopsins. The NIR light-sensitive rhodopsin-carotenoid 
complex with the wavefront shaping technique can be utilized for optogenetics deep inside 
biological tissues. Lower and upper panels represent the schematic images of modification of 
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rhodopsins by retinal analogs and secondary chromophore attachment and their application in the 
cells and organisms, respectively. 
 
     In addition to replacing the chromophore retinal, we are trying to modify the spectral sensitivity 
by attaching a carotenoid as a secondary chromophore. Recently, many enzymes which are related 
with the production of carotenoids have been identified and the heterologous production of target 
carotenoids from its precursors (e.g. -carotene and lycopene) has been achieved in E. coli cells 
and yeasts.82, 83 For the case of mammals, -carotene and lycopene exist in blood serum,84 which 
could ubiquitously supply them to the cells in the whole body. Using the same strategy, we 
speculate that the specific carotenoids can be heterologously produced from its precursors without 
their direct addition in mammalian cells by genetically expressing the enzymes. Carotenoids 
generally absorb light at wavelengths ranging from 400 to 500 nm (violet to green light),85 after 
which the light energy absorbed by the carotenoid as the second chromophore is transferred to the 
first chromophore, retinal. Since rhodopsins mainly absorb light at wavelengths of 500 to 600 nm, 
the attachment of the antenna carotenoid is expected to extend the absorbed wavelength range and 
increase the absorption cross-section for rhodopsin activation (Fig. 5B, lower panel). In fact, an 
outward proton pump rhodopsin named xanthorhodopsin from the bacterium Salinibacter ruber 
forms a complex with the carotenoid salinixanthin (SX) in nature.86 In a collaboration with Dr. 
Sheves, we demonstrated that SX also binds TR and the light energy absorbed by SX is transferred 
to the retinal in the complex.87 Thus, the attachment of an antenna carotenoid can be an effective 
approach to expand the wavelength range at which rhodopsins are activatable. Interestingly, some 
carotenoids have been proven to have an attractive ability, two-photon absorption (excitation) of 
NIR light.88 Therefore, the attachment of such carotenoids as the second chromophore may allow 
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us to produce NIR light-sensitive rhodopsins. Since NIR light is highly transparent in biological 
tissues, using a NIR light-sensitive rhodopsin-carotenoid complex is a promising molecular tool 
for optogenetics deep inside biological tissues (Fig. 5B, upper panel). The wavefront shaping 
technique (Fig. 3) can be combined with the NIR light-sensitive complex, which may enable 
optogenetics in the whole body. 
 
Expansion of optogenetics 
Our research group and others have demonstrated the great potential of microbial rhodopsins as 
optogenetics tools in bacteria, archaea and animals. On the other hand, there has been no report 
that microbial rhodopsins are useful in plants. Ion concentrations are well-known to be related to 
various biological activities of plants as well as animals and microbes.89, 90 As a representative 
example, acidification of the inside of thylakoid membranes is generated by the photosynthetic 
activity of a photosynthetic electron transport chain consisting of photosystem I (PSI), 
photosystem II (PSII) and the cytochrome b6f complex.
91 The proton gradient across thylakoid 
membranes drives the synthesis of ATP by coupling with ATP synthase. We expect that RmXeR 
as an inward proton-transporting rhodopsin can be used to produce proton gradients across 
thylakoid membranes that promote the synthesis of ATP (Fig. 6A, lower panel). Actually, BR 
expressed in the inner mitochondrial membrane could produce proton gradients across the 
membrane as produced by the respiratory chain for ATP synthesis in Schizosaccharomyces 
pombe.92 The chromophore chlorophyll and carotenoids contained in PSI and PSII mainly absorb 
blue and red light (400 – 450 nm and 600 - 700 nm for chlorophyll, and 400 – 500 nm for 
carotenoids) for photosynthesis, while green light ranging from 500 - 600 nm is less utilized as an 
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energy source in plants, which is called the “green-gap” and is a crucial characteristic when 
expressing RmXeR that absorbs green light maximally. Hence, transgenic plants whose thylakoid 
membranes functionally express RmXeR are expected to utilize not only blue and red light but 
also green light for their photosynthesis (Fig. 6A, upper panel). In regions where sunlight is only 
available within a short period, many plants cannot produce sufficient amounts of ATP. This 
problem can be solved by using transgenic plants that can effectively exploit the energy of green 
light. We believe that creating vegetables that can produce ATP with green light would greatly 
expand farmland areas to improve food production.  
 
Figure 6. Unlimited possibilities of microbial rhodopsins. 
(A) Green light induces ATP production in the chloroplasts of plants. Transgenic plants expressing 
RmXeR on their thylakoid membranes are expected to utilize green light for photosynthesis. (B) 
Rhodopsin-based photovoltaic devices. A photovoltaic device consisting of RxR and a conductive 
oxide electrode induces transient photocurrents. (C) Rhodopsin-based method to efficiently collect 
rare metals such as Li+ and Y3+. Long-term light illumination keeps activating rare metals-
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transportable rhodopsin and rare metals are stored and enriched inside rhodopsin-expressing 
membranes. (D) Rhodopsin-based drug delivery system (DDS). Medicinal products and 
supplements are released only upon illumination. As representative medicinal products, dopamine 
and aspirin are shown. Lower and upper panels represent the schematic images of the functions of 
individual rhodopsins and those of their application, respectively. EC and IC indicate extracellular 
and intracellular sides, in all panels, respectively. 
 
     From the viewpoint of physical chemistry, we introduce here the potential of rhodopsins (Figs. 
6B and 6C). Some researchers have produced photovoltaic devices consisting of BR-expressing 
purple membranes from H. salinarum and conductive oxide electrodes such as SnO2 and indium-
tin oxide.93-95 The pH response of the surface oxide electrode due to proton release/uptake by BR 
can induce transient photocurrents in these photovoltaic devices.95, 96 In 2017, we identified an 
extremely thermally-stable rhodopsin (RxR) from the bacterium Rubrobacter xylanophilus (Fig. 
6C, lower panel).97 RxR works as an outward proton pumping rhodopsin as well as BR. As far as 
we know, RxR is the most stable rhodopsin in nature and maintains its activity even at 85°C. Such 
an extremely high stability allows RxR to survive even in the abiotic environments (e.g. high 
temperature, salt-free and anhydrous environments) of photovoltaic devices. Therefore, we expect 
that RxR can be an alternative to BR for application to new photovoltaic devices (Fig. 6B, upper 
panel). 
As mentioned above, we would like to modulate ion selectivity by introducing mutations in 
cation and anion transporters. As part of such a challenge, we would like to produce light-driven 
inward pumps of rare metal ions such as Li+, Y3+ and Nd3+ (Fig. 6C, lower panel). Because rare 
metals are utilized for the production of electric devices and cars, developing a way to efficiently 
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collect rare metals from nature are highly desired.98 If they exist or if we can produce a rhodopsin 
that inwardly pumps rare metal ions, we could collect rare metals from nature using 
proteoliposomes containing an inward rare metal pumping rhodopsin, which would result in the 
enrichment of rare metals (Fig. 6C, upper panel). 
     Finally, we introduce the possible applications of rhodopsins in humans from the viewpoint of 
medical and pharmaceutical sciences. As well as ions, medicinal products and supplements (e.g. 
nucleotides, hormones and related small compounds) often possess positively and negatively 
charged groups such as dopamine and aspirin (Fig. 6D, lower panel). We would like to produce a 
rhodopsin-based transporter by introducing mutations in SyHR having a large ion transport 
pathway. As a rhodopsin-based drug delivery system (DDS),99, 100 we propose the application of 
proteoliposomes containing substrates (medicinal products and supplements) with the engineered-
transporter. The substrates within proteoliposomes would be released only upon irradiation, which 
would allow us to control the timing of substrate release and the amounts of released substrates in 
the body by light (Fig. 6D, upper panel). Therefore, such rhodopsin-based drug delivery systems 
would enable us to precisely control the release and administration of medicinal products and 
supplements in specific regions of the body without undesired side effects. 
 
Conclusion 
In this perspective, we discussed challenges in designing and producing novel rhodopsin-based 
optogenetics tools to optically control a wide variety of biological functions in animals, bacteria, 
archaea and plants. We also considered unlimited future applications of rhodopsins in agriculture, 
physicochemical, medical and pharmaceutical sciences. Thus, a colorful future is ongoing with 
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